TCMVs vaccine triggers individualized immune responses against corresponding tumors and induces more effective and durable anti-tumor immune responses while avoiding tumor cytoplasmic protein interference and immune escape caused by downregulation of partial antigen expression [67,212]. Here, BLZF1 is linked to neoplasm.